3Anderson RE,Hansson LO,Nilsson O,et al.High serum S100B levels for trauma patients without head injures[J].Neurosurgery,2001,48:1255～1260.
4Muley T,Ebert W,Stieber P,et al.Technical performance and diagnosis utility of the new Elycsys neuron-specific enolase enzyme immunoassay[J].Clin Chem Lab Med,2003,41:95～103.
5Beaudeux J,Leger P,Dequen L,et al.Influence of hemolysis on the measurement of S100B protein and neuron-specific enolase plasma concentration during coronary artery bypass grafting[J].Clin Chem,2000,46:989～990.
6Herrmann M,Vos P,Wunder lich MT,et al.Release of glj8l tissuespecific proteins after acute stroke:a comparative analysis of serum concentration of protein S100B and glial fibrillary acidic protein[J].Stroke,2000,31:2670～2677.
7Pelsers MM,Glatz JFC.Detection of brain injure by fatty acidbinding protein.[J].Clin Chem Lab Med,2005,43:802～809.
6Manabat C,Han BH,Wendland M,et al.Reperfusion differentially induces caspase-3 activation in ischemic core and penumbra after stroke in immature brain.Stroke,2003,34(1):207-213.
7Gerriets T,Stolz E,Walberer M,et al.Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion:adverse effects of hypothalamic damage and strategies for its avoidance.Stroke,2003,34(9):2234-2239.
8De-Vry J,Horvath E,Schreiber R.Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620.Eur J Pharmacol,2001,428(2):203-214.
9Carroll RC,Zukin RS.NMDA-receptor trafficking and targeting:implications for synaptic transmission and plasticity.Trends Neurosci,2002,25(11):571-577.
10Shi W,Zhang X,Pintilie M,et al.Dysregulated PTEN-PKB and negative receptor status in human breast cancer.Int J Cancer,2003,104(2):195-203.
